HIV/AIDS
RSSArticles
-
FluBlok The First FDA-Approved Recombinant Seasonal Influenza Vaccine
-
Updates By Carol A. Kemper, MD, FACP
McKittrick N, et al. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons. Ann Intern Med 2013;(158):19-26. -
Rapid Identification of Gastro Pathogens Directly from Stool
On January 14, 2013, that the U.S. FDA approved a device allowing detection of multiple gastrointestinal pathogens from a single sample of feces. -
Surgeon-To-Patient HBV Transmission, CDC Update on Chronically Infected
A surgeon reported having suffered a sharps injury while performing an orthopedic procedure. Baseline testing found no evidence of HBV infection in the source patient, but determined that the surgeon had preexisting HBV infection, with positive HBsAg, positive HBeAg, negative IgM anti-HBc, and normal serum hepatic transaminases. -
Pediatric Tuberculosis in the United States
An analysis was performed of incident cases of tuberculosis in the United States reported to the Centers for Disease Control and Prevention from 2008-2010. -
Delayed Primary Epstein-Barr Virus Infection: Clinical and Immunologic Manifestations
In the United States, approximately 50% of individuals develop antibodies to Epstein-Barr virus (EBV) by age 5. -
Tetracycline Treatment of Mycoplasma Infections in Children
A large outbreak of community acquired pneumonia due to macrolide-resistant M. pneumoniae (MRMP) occurred in Japan in 2011 and mainly affected school-age children. -
Pharmacology Watch: FDA Approves Apixaban for Patients with Nonvalvular AF
In this issue: Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions. -
Pharmacology Watch: New Study on Chelation Therapy Proves Controversial
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions. -
Clinical Briefs in Primary Care supplement